Rodeo Therapeutics Company
Rodeo Therapeutics is a developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types.
Technology:
Immunotherapy
Industry:
PharmTech
Headquarters:
Seattle, Washington, United States
Founded Date:
2017
Employees Number:
1-10
Funding Status:
M&A
Estimated Revenue:
$10M to $50M
Register and Claim Ownership